Cargando…
Forced expression of S100A10 reduces sensitivity to oxaliplatin in colorectal cancer cells
BACKGROUND: Individual responses to oxaliplatin (L-OHP)-based chemotherapy remain unpredictable. Our recent proteomics studies have demonstrated that intracellular protein expression levels of S100A10 are significantly correlated with the sensitivity of colorectal cancer (CRC) cells to L-OHP, but no...
Autores principales: | Suzuki, Sayo, Tanigawara, Yusuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029833/ https://www.ncbi.nlm.nih.gov/pubmed/24851084 http://dx.doi.org/10.1186/1477-5956-12-26 |
Ejemplares similares
-
S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells
por: Suzuki, Sayo, et al.
Publicado: (2011) -
Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer
por: Yamada, Y, et al.
Publicado: (2008) -
Quercetin-Induced Glutathione Depletion Sensitizes Colorectal Cancer Cells to Oxaliplatin
por: Lee, Jinkyung, et al.
Publicado: (2023) -
Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells
por: Gonçalves-Ribeiro, Samuel, et al.
Publicado: (2016) -
Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer
por: Zhang, Bo, et al.
Publicado: (2021)